1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Motherisk Nausea and Vomiting of Pregnancy (NVP) ForumMotherisk receives questions from around the world about morning sickness symptoms, effects, treatments and ways to cope. Those questions and answers are posted here for anyone to read, provided the reader acknowledges and accepts the proviso and disclaimer below.
I was taking regular doses of Diclectin from 8-11 weeks (4 tablets/day). However the dosage did not appear to be strong enough to curb my NVP. My physician recommended I take 6 tablets a day as the regular 4 were not working. I did this for 3 weeks. My NVP has settled down now (at 16 weeks) and I have stopped taking Diclectin altogether. I am concerned with the fact that I was taking a dosage beyond the recommended dosage (4 tablets). Do you have any information about the increased effects of taking a dosage beyond the maximum recommended dosage?
We are pleased to hear that at 16 weeks your NVP symptoms have stopped, as is the case for most women. Diclectin is known not to increase the baseline risk of malformation of 1% to 3% present in any pregancy. Four pills per day is the dosage commonly used by most women, not taking their body weight into consideration. However, women with severe symptoms (or heavier weights)who are not relieved by 4 pills daily have been taking larger doses. We recently completed a study with women who were taking up to 8 pills per day. There is no difference in birth defect rates in this group when compared with the group that took 4 pills per day, or any increase in the baseline risk of 1% to 3%.